GUILLAIN-BARRE SYNDROME, ASSOCIATED WITH COVID-19 IN THE REPUBLIC OF SAKHA (YAKUTIA)
https://doi.org/10.25587/SVFU.2022.29.4.004
Abstract
Guillain-Barre syndrome (GBS) is a rare, severe disease of peripheral nerves and nerve roots, which is usually caused by infections. Since the beginning of the pandemic of the new coronavirus infection COVID-19, numerous cases of Guillain-Barre syndrome have been presented in scientific publications, which developed in patients at various times after suffering the new coronavirus infection. The purpose of this study was to investigate the features of the development and course of GBS associated with COVID-19. Nine patients with an established diagnosis of GBS were examined, with six of them being infected with the SARS-CoV2 virus. A comparative study of the features of the course and severity of the disease was carried out in two groups: the main group – GBS associated with COVID-19; and the control group – GBS without COVID-19. Based on the data obtained, it can be said that GBS against the background of the new coronavirus infection develops more often in men over the age of 50 and proceeds much more severely than GBS unrelated to COVID-19. Axonal lesions with a longer and incomplete recovery of motor functions, with the development of severe respiratory failure requiring prolonged ventilation, were significantly more common in patients with COVID-19.
About the Authors
T. Ya. Nikolaeva
M.K. Ammosov North-Eastern Federal University
Russian Federation
Russian Federation
NIKOLAEVA Tatiana Yakovlevna – Doctor of Medical Sceinces, Head of the Department of Neurology and Psychiatry, Institute of Medicine
677000, Yakutsk, ul. Belinskogo, 58
K. E. Osipova
M.K. Ammosov North-Eastern Federal University
Russian Federation
Russian Federation
OSIPOVA Kunnei Evgenievna – resident of the Department of Internal Diseases and General Medical Practice Institute of Medicine
677000, Yakutsk, ul. Belinskogo, 58
A. Yu. Petrova
Sakha Republic (Yakutia) Hospital No. 2 – Center for Emergency Medicine
Russian Federation
Russian Federation
PETROVA Alyona Yuryevna – Head of the Neurological Department
677000, Yakutsk, ul. Petra Alekseeva, 83A
References
1. Leonhard S.E. et al. Diagnosis and management of Guillain–Barré syndrome in ten steps / // Nature Reviews Neurology. – 2019. – Vol. 15(11). – P.671–683.
2. Sejvar, J. J., Baughman, A. L., Wise, M. & Morgan, O. W. Population incidence of Guillain-Barré syndrome: a systematic review and meta-analysis. // Neuroepidemiology. – 2011. Vol. 36. – P.123–133.
3. Piradov M. A. Guillain-Barre syndrome: diagnosis and treatment: a guide for doctors / M. A. Piradov, N. A. Suponeva. – M.: MEDpress, 2011. – 208 p.
4. Grishina D. A., Devlikamova F.I., Zinovieva O.E., Kurenkov A.L., Nikitin S.S., Piradov M.A., Suponeva N.A. Guillain–Barre syndrome in adults. Federal Clinical guidelines. – M., 2020. – 39 p.
5. Filosto M. et al Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions. J Neurol Neurosurg Psychiatry. 2021 Jul;92(7):751-756. doi: 10.1136/jnnp-2020-324837. Epub 2020 Nov 6. PMID: 33158914; PMCID: PMC7650204.
6. Sedaghat Z., Karimi N. Guillain Barre syndrome associated with COVID-19 infection: a case report // J. Clin. Neurosci. – 2020. – Vol. 76. – P. 233-235.
7. Selitsky M. M. et al. Guillain–Barre syndrome associated with COVID–19 // Medical business: scientific and practical therapeutic journal. – 2021. – № 3(78). – P. 41-47.
8. Chakraborty U. Covid-19 associated Guillain-Barré syndrome: A series of a relatively uncommon neurological complication / U. Chakraborty, A. Hati, A. Chandra // Diabetes & Metabolic Syndrome: Clinical Research & Reviews. – 2021. – Vol.15(6). – 102326.
9. Finsterer J. Guillain-Barre syndrome in 220 patients with COVID-19 / J. Finsterer, F.A. Scorza // The Egyptian Journal of Neurology, Psychiatry and Neurosurgery. – 2021. – Vol.57(1). – P. 55.
10. Gittermann L.M.T. Relation Between COVID–19 and Guillain–Barré Syndrome in Adults: A Systematic Review / L.M.T. Gittermann, S.N.V. Feris, A.v.O. Giacoman // Neurología. – 2020. – Vol. 35. – P.646–654.
11. COVID-19-Associated Guillain-Barre Syndrome: Atypical Para-infectious Profile, Symptom Overlap, and Increased Risk of Severe Neurological Complications / M.M. Kajumba [et al.] // SN Comprehensive Clinical Medicine. – 2020. – Vol. 2(12). – P.2702-2714.
12. Guillain–Barré syndrome and COVID–19: an observational multicentre study from two Italian hotspot regions / M. Filosto [et al.] // Journal of Neurology, Neurosurgery, and Psychiatry. – 2021. – Vol. 92(7). – P.751– 756.
13. Van den Berg B. Mortality in Guillain-Barre syndrome / B. van den Berg, C. Bunschoten, P.A. van Doorn, B.C. Jacobs // Neurology. – 2013. – Vol. 80(18). – P.1650-1654.
Review
For citations:
Nikolaeva T.Ya., Osipova K.E., Petrova A.Yu. GUILLAIN-BARRE SYNDROME, ASSOCIATED WITH COVID-19 IN THE REPUBLIC OF SAKHA (YAKUTIA). Vestnik of North-Eastern Federal University. Medical Sciences. 2022;(4):43-50. (In Russ.) https://doi.org/10.25587/SVFU.2022.29.4.004
Views:
226
Email this article 